Amount Raised
£24 Million
Round Type
Series A
LondonOtherBiotechnologyHealth CareTherapeuticsDescription
Centauri Therapeutics Limited (Centauri), an immunotherapy company founded by Animatrix Founders LLP and focused on the treatment of infectious diseases, today announced the close of its £24 million GBP (c. 32 million USD) Series A investment round. The funds will support the continued advancement of the Company’s antimicrobial resistance (AMR) research and development, using the Alphamer® platform to identify and progress novel antibacterial candidates through first-in-human trials, for difficult-to-treat infections.
Quick answer
Centaurus Therapeutics raised £24 Million in a Series A round, dated February 16, 2022. Centaurus Therapeutics is based in London, England, United Kingdom.
- How much did Centaurus Therapeutics raise?
- Centaurus Therapeutics raised £24 Million in a Series A round on February 16, 2022.
- What does Centaurus Therapeutics do?
- Centauri Therapeutics Limited is a UK-based biotechnology company developing novel treatments for life-threatening diseases using its proprietary Alphamer technology.
- Where is Centaurus Therapeutics based and how big is it?
- Centaurus Therapeutics is based in London, England, United Kingdom.
- Who are the decision-makers at Centaurus Therapeutics?
- Fundz holds 1 contact at Centaurus Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Centaurus Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- KayoThera, Inc. raised $10M (Series A) on March 24, 2022.
- Theriva Biologics raised $1.5M (Seed) on March 21, 2022.
- KayoThera, Inc. raised $8M (Series A) on March 16, 2022.
- MAIA Biotechnology raised $2.4M (Seed) on March 16, 2022.
- Tevogen Inc. raised an undisclosed amount (Funding Round) on March 15, 2022.
- Scipher Medicine raised $110M (Funding Round) on February 24, 2022.
Who to call at Centaurus Therapeutics, and when
A new round usually means Centaurus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Centaurus Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Centaurus Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Centaurus Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Centaurus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCentaurus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.